Laurie A Minns

Title: The Innovative Contributions of Laurie A. Minns

Introduction

Laurie A. Minns is a notable inventor based in Shoreline, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of methods that influence immune responses. Her work is characterized by a focus on innovative solutions that address complex biological challenges.

Latest Patents

Laurie A. Minns holds a patent for a method titled "Method for inducing a TRIF-bias." This patent involves the use of a selected aminoalkyl glucosaminide 4-phosphate (AGP) CRX-547 to induce a TRIF biased response in a human system. The method results in reduced levels of MyD88-dependent cytokines compared to those induced by its diastereomer AGP CRX-527. This innovation has the potential to advance therapeutic strategies in immunology.

Career Highlights

Laurie A. Minns is currently employed at GlaxoSmithKline Biologicals SA, where she continues to contribute to groundbreaking research and development in the pharmaceutical industry. Her expertise and innovative mindset have positioned her as a valuable asset in her field.

Collaborations

Laurie has collaborated with esteemed colleagues, including William S. Bowen and Jay T. Evans. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in their research endeavors.

Conclusion

Laurie A. Minns exemplifies the spirit of innovation in biotechnology through her patent and contributions at GlaxoSmithKline Biologicals SA. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.